top of the page
man reading a newspaper

Case Studies

Case Studies

11th March 2022

Elasmogen

11th March 2022

Cazoo

11th March 2022

3-SIXTY

11th March 2022

AutoLab Car Services

11th March 2022

Simfoni

11th March 2022

GTS Flexible Materials

22nd February 2022

Nova Pangaea Technologies

15th March 2021

Shawbrook Bank

15th March 2021

Wilton and Bain Group Limited

15th March 2021

Unily

15th March 2021

Transcend Packaging

15th March 2021

The Technology Group

15th March 2021

One Utility Bill

15th March 2021

Laird London

15th March 2021

Hannah Woodgates Hair Design

15th March 2021

Alexander Technologies

Elasmogen

BBI Programme: Regional Angels
Delivery partner: Deepbridge Capital

Part of a cluster of biotech companies in Aberdeen, Elasmogen uses its bespoke technology platform to isolate innovative drugs for treating cancers and auto-immune diseases.

With a strong foundation of intellectual property and a healthy pipeline of new programmes, Elasmogen had progressed several innovative drugs to the late pre-clinical stage. Finance is vital at this early research and development stage.

Funding from Regional Angels Programme delivery partner Deepbridge has added value to the company’s platform, processes and products – and helped to retain its talented team. Elasmogen is now in a position to consider its next major milestone: entering clinical trials.

“ It has transformed our ability to demonstrate the advantages of our technology over the competition.”

Caroline Barelle, CEO

image of a scientist in a lab

back to case studiesBACK